Literature DB >> 16867906

Marked hepatomegaly due to AA type amyloidosis in a case with Castleman's disease.

Noboru Yamagata1, Jyunko Fujio, Risen Hirai, Mutsumi Matsumaru, Satoshi Tanimura, Chiho Inokuchi, Tateki Shikai, Naoki Takezako, Michiyo Nasu, Yoichi Sakata, Naohiro Sata, Hideo Nagai, Ken Saito, Akiyoshi Miwa.   

Abstract

Hepatic amyloidosis complicated with Castleman's disease is quite rare. A 48-year-old woman was referred to our hospital with general fatigue, low-grade fever, anemia, thrombocythemia, and liver dysfunction. Physical examination revealed anemia and hepatomegaly and abdominal computed tomography showed marked hepatomegaly and right upper abdominal masses. Technetium-99m pyrophosphate (99mTc-PYP) scintigraphy revealed the diffuse abnormal uptake of the enlarged liver, suggesting amyloid deposition. Liver biopsy showed destruction of the liver structure and the massive deposition of AA type amyloid protein. Surgical resection was performed on the abdominal masses. Histological examination of the masses showed Castleman's disease (plasma cell type). After resection, her fever resolved and the liver size gradually decreased to within the normal range. This case shows that surgical resection of the main lesion is effective for hepatomegaly due to AA type amyloidosis associated with Castleman's disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16867906     DOI: 10.1532/IJH97.05126

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  20 in total

Review 1.  Secondary amyloidosis in Castleman's disease: review of the literature and report of a case.

Authors:  M R Altiparmak; G E Pamuk; O N Pamuk; G Doğusoy
Journal:  Ann Hematol       Date:  2002-05-17       Impact factor: 3.673

2.  Systemic reactive amyloidosis associated with Castleman's disease: serial changes of the concentrations of acute phase serum amyloid A and interleukin 6 in serum.

Authors:  S Ikeda; H Chisuwa; S Kawasaki; J Ozawa; Y Hoshii; T Yokota; T Aoi
Journal:  J Clin Pathol       Date:  1997-11       Impact factor: 3.411

3.  Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations.

Authors:  A R Keller; L Hochholzer; B Castleman
Journal:  Cancer       Date:  1972-03       Impact factor: 6.860

Review 4.  Secondary (AA) amyloidosis associated with Castleman's disease. Report of two cases and review of the literature.

Authors:  J Ordi; J M Grau; A Junqué; B Nomdedeu; A Palacin; A Cardesa
Journal:  Am J Clin Pathol       Date:  1993-10       Impact factor: 2.493

5.  Castleman disease and renal amyloidosis.

Authors:  I Kazes; G Deray; C Jacobs
Journal:  Ann Intern Med       Date:  1995-03-01       Impact factor: 25.391

6.  Systemic amyloidosis associated with a benign mesenteric lymphoid mass.

Authors:  V A Pilon; L G Gomez; J J Butler
Journal:  Am J Clin Pathol       Date:  1982-07       Impact factor: 2.493

7.  Castleman's disease and mesangial proliferative glomerulonephritis: the role of interleukin-6.

Authors:  S L Lui; K W Chan; F K Li; I K Cheng; T M Chan
Journal:  Nephron       Date:  1998       Impact factor: 2.847

8.  Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosis.

Authors:  R H Falk; V W Lee; A Rubinow; W B Hood; A S Cohen
Journal:  Am J Cardiol       Date:  1983-03-01       Impact factor: 2.778

9.  Abnormal scintigraphic evolution in AA hepatic amyloidosis.

Authors:  F Lomeña; R Roselló; F Pons; M Grau; A García; A Catafau; J Setoain
Journal:  Clin Nucl Med       Date:  1988-03       Impact factor: 7.794

Review 10.  Localized Castleman's disease and nephrotic syndrome not responsive to resection plus colchicine therapy.

Authors:  U Derici; T Arinsoy; O Ataoglu; M Bali; A Eroglu; B Goker; S Sindel
Journal:  Ann Hematol       Date:  2002-06-25       Impact factor: 3.673

View more
  4 in total

Review 1.  An autopsy case of multicentric Castleman's disease associated with interstitial nephritis and secondary AA amyloidosis.

Authors:  Yuriko Morita-Hoshi; Shuji Tohda; Osamu Miura; Nobuo Nara
Journal:  Int J Hematol       Date:  2007-12-08       Impact factor: 2.490

2.  Amyloidosis secondary to intrapulmonary Castleman disease mimicking pulmonary hyalinizing granuloma-like clinical features: A rare case report.

Authors:  Shao-Ting Wang; Qi-Pu Wang; Ji Li; Ting Zhang; Lu Zhang; Yue-Ying Mao
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

3.  Systemic Reactive Amyloidosis Associated with Castleman's Disease.

Authors:  Vinaya Gaduputi; Hassan Tariq; Kanthi Badipatla; Ariyo Ihimoyan
Journal:  Case Rep Gastroenterol       Date:  2013-11-12

Review 4.  AA amyloidosis associated with Castleman disease: A case report and review of the literature.

Authors:  Luca Bernabei; Adam Waxman; Gabriel Caponetti; David C Fajgenbaum; Brendan M Weiss
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.